Keywords
How to Cite
Share
Abstract
The frecuent drug use can produce disturbances in executive functions, affecting the mental health of the people. The main objetive of the study was to compare the performance in the evaluation of the executive functions between students with tobabco use, weed comsumers and no drug users. For that the BANFE-3 was used, also an initial interview with questions about the sociodemographic status and general health status, for determinate the drug use the ASSIST test, the CAST test and the Fagerström test were used. A total of 30 participants were evaluated, 10 control participants, 10 tobacco users and 10 weed users. In the results, was found a lower performance in the inhibitoty control and decision making in the group of weed users. In regarding to the tobacco users the time of using was correlated with a lower performance in the verbal fluency and visuospacial memory.
References
activation likelihood estimation meta-analytic study. Archives of Clinical Neuropsychology, 33(4), 379–405. https://pubmed.ncbi.nlm.nih.gov/28961762/
Bolaños, P., y Chacón, C. (2017). Intoxicacion por monoxido de carbono. Medicina Legal de Costa Rica, 34(1), 137-146. https://www.scielo.sa.cr/scielo.phpscript=sci_arttext&pid=S1409-00152017000100137
Cohen, L. B., y Neuman, M. G. (2020). Cannabis and the Gastrointestinal Tract. Journal of Pharmacy and Pharmaceutical Sciences, 23, 304-313. https://doi.org/10.18433/jpps31242
Coullaut-Valera, R., Arbaiza-Díaz Del Río, I., De Arrúe-Ruiloba, R., Coullaut-Valera, J., y Bajo-Bretón, R. (2011). Deterioro cognitivo asociado al consumo de diferentes sustancias psicoactivas. Actas Especiales Psiquiatría, 39(3), 168–173.
Durazzo, T. C., Meyerhoff, D. J., y Nixon, S. J. (2012). A comprehensive assessment of neurocognition in middle-aged chronic cigarette smokers. Drug and Alcohol Dependence, 122(1–2), 105–111. https://doi.org/10.1016/j.drugalcdep.2011.09.019
European Medicines Agency. (2011). ICH guideline S6 (R1) – preclinical safety evaluation of biotechnology-derived pharmaceuticals. En Committee For Medicinal Products For Human Use. https://www.ema.europa.eu/en/documents/scientificguideline/ich-s6r1-preclinical-safety-evaluation-biotechnology-derivedpharmaceuticals-step-5_en.pdf
Feingold, D., & Weinstein, A. (2021). Cannabis and Depression. Advances in experimental medicine and biology, 1264, 67–80. https://doi.org/10.1007/978-3-030-57369-0_5
Flaudias, V., Picot, M. C., López-Castromán, J., Llorca, P., Schmitt, A., Perriot, J., Georgescu, V., Courtet, P., Quantin, X., y Guillaume, S. (2016). Executive functions in tobacco dependence: Importance of inhibitory capacities. PLOS ONE, 11(3), e0150940. https://doi.org/10.1371/journal.pone.0150940
Flores, J., Ostrosky, F., & Lozano, A. (2021). BANFE-3: Batería Neuropsicológica de Funciones Ejecutivas y Lóbulos Frontales. Editorial Manual Moderno.
Frolli, A., Ricci, M. C., Cavallaro, A., Lombardi, A., Pastorino, G. M. G., y Operto, F. F. (2020). Executive Functions and Cannabis Use in Adolescents. Preprints, 1(499). https://doi.org/10.20944/preprints202007.0499.v1
Gonzales, M. (27 de febrero de 2020). What Kind of Drug Is Marijuana?. Drug Rehab. https://www.drugrehab.com/addiction/drugs/marijuana/what-kind-of-drug-is-marijuana/
Heatherton, T., Kozlowski, L., Frecker, R. y Fagerström, K. (1991). The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. British Journal of Addiction, 86, 1119-1127.
Helena, M. D. C., Ivone, C., Peña, K., Sandoval, M., Zamudio, J., y Prieto, A. (2016). Efectos fisiológicos de Cannabis sativa en universitarios consumidores. Editorial Universidad Distrital Francisco José de Caldas.
Humeniuk, R., Ali, R., Babor, T. F., Farrell, M., Formigoni, M. L., Jittiwutikarn, J., de Lacerda, R. B., Ling, W., Marsden, J., Monteiro, M., Nhiwatiwa, S., Pal, H., Poznyak, V., y Simon, S. (2008). Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction (Abingdon, England), 103(6), 1039–1047. https://doi.org/10.1111/j.1360-0443.2007.02114.x
Instituto Nacional de Salud Pública. (2023). Encuesta Global de Tabaquismo en Adultos. México 2023. Instituto Nacional de Salud Pública. https://www.gob.mx/cms/uploads/attachment/file/895921/REPORTE_COMPLETO_GATS_2023.pdf
Kaag, A. M., Goudriaan, A. E., De Vries, T. J., Pattij, T., y Wiers, R. W. (2017). A high working memory load prior to memory retrieval reduces craving in non-treatment seeking problem drinkers. Psychopharmacology, 235(3), 695-708. https://doi.org/10.1007/s00213-017-4785-4
Kivimaki, M., & Singh-Manoux, A. (2024). Cognitive Stimulation for Long-Term Cognitive Health. Neurology, 102(9). https://doi.org/10.1212/wnl.0000000000209484
Kozak, K., y Antosiewicz, D. M. (2023). Tobacco as an efficient metal accumulator. Biometals, 36(2), 351–370. https://doi.org/10.1007/s10534-022-00431-3
Kratz, J. W., y Garcia, M. (2018). Manual sobre cannabis medicinal. Formación en el uso profesional y responsable de cannabinoides y terpenos. (1.a ed.). Kalapa Clinic. https://medicinainterna.net.pe/sites/default/files/Manual%20sobre%20Cannabis%20Medicinal.pdf
Legleye, S., Karila, L., Beck, F., y Reynaud, M. (2009). Validation of the CAST, a general population Cannabis Abuse Screening Test. Journal of Substance Use, 12, 233–242.
Lovell, M. E., Bruno, R., Johnston, J., Matthews, A., McGregor, I. S., Allsop, D., y Lintzeris, N. (2018). Cognitive, physical, and mental health outcomes between long-term cannabis and tobacco users. Addictive Behaviors, 79, 178–188. https://doi.org/10.1016/j.addbeh.2017.12.009
Lyvers, M., Carlopio, C., Bothma, V., y Edwards, M. S. (2014). Mood, mood regulation, and frontal systems functioning in current smokers, Long-Term abstinent Ex-Smokers, and Never-Smokers. Journal of Psychoactive Drugs, 46(2), 133–139. https://doi.org/10.1080/02791072.2013.876522
Mantero Suárez, G. (2018). Sistema de recompensa del cerebro y neuronas del placer [Tesis de grado]. Universidad de Sevilla.
McHale, S., y Hunt, N. (2008). Executive function deficits in short‐term abstinent cannabis users. Human Psychopharmacology-clinical and Experimental, 23(5), 409–415. https://doi.org/10.1002/hup.941
Messinis, L., Kyprianidou, A., Malefaki, S., y Papathanasopoulos, P. (2006). Neuropsychological deficits in long-term frequent cannabis users. Neurology, 66(5), 737–739. https://doi.org/10.1212/01.wnl.0000201279.83203.c6
Milnerowicz, H., Ściskalska, M., y Dul, M. (2015). Pro-inflammatory effects of metals in persons and animals exposed to tobacco smoke. Journal of Trace Elements in Medicine and Biology, 29, 1–10. https://doi.org/10.1016/j.jtemb.2014.04.008
Morales, P., Hurst, D.P., Reggio, P.H. (2017). Molecular Targets of the Phytocannabinoids: A Complex Picture. En: Kinghorn, A., Falk, H., Gibbons, S., Kobayashi, J. (Eds) Phytocannabinoids. Progress in the Chemistry of Organic Natural Products, vol 103. Springer, Cham. https://doi.org/10.1007/978-3-319-45541-9_4
Organización Panamericana de la Salud. (2011). La prueba de detección de consumo de alcohol, tabaco y sustancias (ASSIST) –Manual para uso en la atención primaria.
Organización Mundial de la Salud. https://www.seccatid.gob.gt/images/Docs_CTA/Assist-la-prueba-dedeteccion.pdf
Perry, J. L., & Carroll, M. E. (2008). The role of impulsive behavior in drug abuse. Psychopharmacology, 200(1), 1-26. https://doi.org/10.1007/s00213-008-1173-0
Rosales, M., Cruz-Morales, S. E. C., y Lira-Mandujano, J. (2018). Funciones ejecutivas como predictores del consumo y la dependencia al tabaco. Panamerican Journal of Neuropsychology, 12(3), 18-37. https://doi.org/10.7714/cnps/12.3.202
Selamoglu, A., Langley, C., Crean, R. D., Savulich, G., Cormack, F., Sahakian, B. J., y Mason, B. J. (2021). Neuropsychological performance in young adults with cannabis use disorder. Journal of Psychopharmacology, 35(11), 1349–1355. https://doi.org/10.1177/02698811211050548
Tashkin, D. P. (2013). Effects of marijuana smoking on the lung. Annals of the American Thoracic Society, 10(3), 239–247. https://doi.org/10.1513/annalsats.201212-127fr
Thomas, G., Kloner, R. A., y Rezkalla, S. H. (2014). Adverse Cardiovascular, Cerebrovascular, and Peripheral Vascular Effects of Marijuana Inhalation: What Cardiologists Need to Know. American Journal of Cardiology, 113(1), 187-190. https://doi.org/10.1016/j.amjcard.2013.09.042
Villatoro-Velázquez, J. A., Resendiz, E., Mujica, A., Bretón-Cirret, Cañas-Martínez, V., Soto-Hernández, I., Fregoso-Ito, Fleiz-Bautista, C., Medina-Mora, M. E., Gutiérrez-Reyes, J., Franco-Núñez, J., Romero-Martínez, M., y MendozaAlvarado, L. (2017b). Encuesta Nacional de Consumo de Drogas, Alcohol y Tabaco 2016-2017: Reporte de Drogas. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Instituto Nacional de Salud Pública, Comisión Nacional Contra las Adicciones, Secretaría de Salud.https://drive.google.com/file/d/1rMlKaWy34GR51sEnBK2-u2q_BDK9LA0e/view
Wanmaker, S., Leijdesdorff, S., Geraerts, E., Van De Wetering, B., Renkema, P. J., y Franken, I. H. (2017). The efficacy of a working memory training in substance use patients: a randomized double-blind placebo-controlled clinical trial. Journal of Clinical and Experimental Neuropsychology, 40(5), 473-486. https://doi.org/10.1080/13803395.2017.1372367
Yayan, J., & Rasche, K. (2016). Damaging Effects of Cannabis Use on the Lungs. Advances in experimental medicine and biology, 952, 31–34. https://doi.org/10.1007/5584_2016_71
Zaveri, N. T., Rollema, H., & Swan, G. E. (2015). Nicotine dependence. Progress in respiration research, 42, 47–57. https://doi.org/10.1159/000369324
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 Enseñanza e Investigación en Psicología